Publications:
←Older revision
Revision as of 12:40, 11 September 2013
Line 6:
Line 6:
*Benjamin Hirschi
*Benjamin Hirschi
*Helmholtz Center Munich
*Helmholtz Center Munich
-
*
Address 1
+
*
Institute of Stem Cell Research
-
*
Address 2
+
*
Ingolstädter Landstr. 1
-
*
City
,
State
,
Country etc.
+
*
D-85764 Neuherberg
,
BY
,
Germany
*[[Special:Emailuser/Benjamin Hirschi|Email me through OpenWetWare]]
*[[Special:Emailuser/Benjamin Hirschi|Email me through OpenWetWare]]
-
I work in the
[[Your Lab]]
at
XYZ University. I learned about [[OpenWetWare]] from Some months ago I was looking
for
E
.
coli genotypes and found your comprehensive list via google., and I've joined because I would like
to
contribute a protocol. And I have questions suggestions
for
an existing protocol
and
would like to have contact to the regarding contributor
..
+
I work in the
Scheel lab focusing on mammary stem cells and breast cancer
at
the Helmholtz Center Munich (German Research Center
for
Environmental Health)
.
My main project is
to
establish protocols
for
immortalization
and
transformation of primary cells from healthy donors using pathophysiologically relevant genetic events (i.e
.
, mutations that do occur in breast cancer)
.
==Education==
==Education==
<!--Include info about your educational background-->
<!--Include info about your educational background-->
-
*
Year
, PhD,
Institute
+
*
2012
, PhD,
LMU Munich (Germany)
,
University Hospital Munich
,
Department of Internal Medicine II
-
* Year
,
MS
,
Institute
+
*
2006, Diploma
,
WWU Münster (Germany)
, Institute
of Biochemistry
-
*
Year
,
BS
, Institute
+
==Research interests==
==Research interests==
<!-- Feel free to add brief descriptions to your research interests as well -->
<!-- Feel free to add brief descriptions to your research interests as well -->
-
#
Interest 1
+
#
Cancerogenesis in breast cancer: Are the different subtypes of breast cancer determined by the cell of origin, or subtype-specific genetic events ... or maybe both?
-
#
Interest
2
+
#
Oncogenic transformation: Can primary cells from healthy donors get <i>in vitro</i>-transformed into cancer cells by applying physiological mechanisms? And will transformation happen in a
2
-step process (i.e., immortalization and subsequently oncogenic transformation)?
-
#
Interest 3
+
#
Cell line establishment: Can we create isogenic cell lines in order to compare immortalized primary cells to their corresponding oncogenic nemesis?
+
# Breast cancer models: Will such corresponding/isogenic cell lines be suitable to model carcinogenesis <i>in situ</i> when cultivated in a 3D environment?
==Publications==
==Publications==
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed -->
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed -->
<biblio>
<biblio>
-
#Paper1 pmid=
6947258
+
#Paper1 pmid=
23354951
-
#Paper2 pmid=
13718526
+
// PhD project
-
//
leave a comment about a paper here
+
#Paper2 pmid=
21179475
-
#
Book1 isbn
=
0879697164
+
//
PhD side show project
+
#
Paper3 pmid
=
21779451
+
// containing results of my diploma thesis
</biblio>
</biblio>